uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Reagila
Authorised
Human
Details
EMA number
EMEA/H/C/002770
ATC code
N05AX15
Authorisation
13 July 2017
Revision
12
EMA page
Therapeutic indication
Reagila is indicated for the treatment of schizophrenia in adult patients.
MeSH:
Schizophrenia
Group:
Psycholeptics
Active substances
cariprazine hydrochloride
Marketing Authorisation Holder
Gedeon Richter
MAH
Timeline
Filter by authority:
EMA
Reagila authorised
13 Jul 2017
authorised
regulatory
Reagila | uMedical